Impact of COVID-19 on Business Performance and Financial Position
First written in FY2020. 5 of 12 entries say "Restated". Latest entry: FY2024-Q2.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024-Q2RestatedAnnual report
「During the first 6 months of the fiscal year, the Japanese economy progressed toward normalization as activity restrictions were eased following the reclassification of COVID-19, while personal consumption and inbound demand were beginning to recover.」
The company has reaffirmed its recognition that economic normalization and demand recovery are progressing following the reclassification of COVID-19 and the easing of activity restrictions. - FY2024-Q1MitigatedAnnual report
「During the first 3 months of the fiscal year ended 31 January 2024 (1 February 2023 to 30 April 2023), socioeconomic activity in Japan was progressing toward normalization following the reclassification of COVID-19 under the Infectious Diseases Control Law to Category 5 on 8 May.」
The company states that socioeconomic activity is normalizing following the reclassification of COVID-19 as a Category 5 disease, reducing the impact previously associated with activity restrictions. - FY2023-Q3RestatedAnnual report
「During the first 9 months of the fiscal year ended 31 January 2023 (1 February 2022 to 31 October 2022), the Japanese economy saw a rapid resurgence of infections described as the seventh wave of COVID-19. However, economic activity has been moving toward normalization because the country was able to observe an extended holiday period and the summer vacation season without activity restrictions.」
The company has reaffirmed its recognition that, despite the resurgence of infections during the seventh wave of COVID-19, economic activity is normalizing without activity restrictions. - FY2023-Q2MitigatedAnnual report
「During the seventh wave, there were no restrictions on activities such as the previous declarations of a state of emergency, and socioeconomic activity is gradually returning to normal.」
The company states that, although infections spread during the seventh wave, there were no restrictions on activities as in the past and socioeconomic activity is gradually normalizing. - FY2023-Q1WorsenedAnnual report
「However, sales activities were adversely affected by mobility and contact restrictions after priority preventive measures were implemented following the resurgence of COVID-19 infections caused by the Omicron variant.」
The company explains that the resurgence of COVID-19 and priority preventive measures continued to affect sales activities through mobility and contact restrictions. - FY2022-Q3RestatedAnnual report
「Although vaccination against COVID-19 is progressing in Japan and the economy is expected to recover as economic activity resumes, supported by the effects of various policies, the situation remains unpredictable due to the spread of highly transmissible variants and ongoing concerns about breakthrough infections.」
The company has reaffirmed its recognition that uncertainty related to the pandemic will persist, despite expectations for vaccination and the resumption of economic activity, because concerns remain about the spread of variants and breakthrough infections. - FY2022-Q2RestatedAnnual report
「The Japanese economy remains in an uncertain situation, as the impact on corporate activity and socioeconomic activity has been prolonged by repeated declarations of a state of emergency and expansions and extensions of priority preventive measures in response to the spread of COVID-19.」
The company has reaffirmed its recognition of the risk that the impact of COVID-19 on corporate and socioeconomic activity will be prolonged and that the outlook remains uncertain. - FY2021MaterialisedAnnual report
「The entire previous year could be described as the “COVID-19 fiscal year.” As a result, our original 50th anniversary commemorative projects had to be fundamentally reexamined.」
Reporting that COVID-19 caused an actual business impact that forced a review of the commemorative projects. - FY2021-Q3RestatedAnnual report
「The timing of the end of the COVID-19 pandemic remains uncertain, making it difficult to accurately predict its impact, and difficult economic conditions are expected to continue. If the situation becomes more prolonged, it may have a further adverse effect on the global economy and, consequently, may affect the operating results and financial position of our group.」
Continuing to identify as risks the uncertainty over when the COVID-19 pandemic will end and its potential impact on the global economy and business results if it becomes prolonged. - FY2021-Q2WorsenedAnnual report
「The timing of the end of the COVID-19 pandemic remains uncertain, making it difficult to accurately predict its impact, and difficult economic conditions are expected to continue. If the situation becomes more prolonged, it may have a further adverse effect on the global economy and, consequently, may affect the operating results and financial position of our group.」
Adding COVID-19 separately as a new business and other risk, and indicating the uncertainty over when it will end and the potential additional impact on the global economy and business results if it becomes prolonged. - FY2021-Q1MaterialisedAnnual report
「As the infection spread in Japan as well, everything, including the sales promotion activities for the 50th anniversary commemorative initiatives, disappeared or was frozen.」
Regarding COVID-19, which was identified as a risk in the previous fiscal year, reporting that the domestic spread of the disease caused commemorative projects and promotional activities to be canceled or suspended, and resulted in specific business impacts, including the suspension of sales activities for household and commercial products. - FY2020First statedAnnual report
「COVID-19, which became apparent in January, is spreading worldwide and may affect the operating results and financial position of our group, although it is difficult to make a reasonable forecast as of the filing date.」
Explicitly identifying the global spread of COVID-19 as a new risk whose impact on operating results and financial position is difficult to predict reasonably. Although the occurrence of the disease itself is described, the disclosure does not state that an impact on the company’s business results has actually occurred.